These results indicate that MR inhibited the expression of the pro-inflammatory pathway proteins TLR4 and TLR9, increased the expression of tight junction proteins, and thereby helped maintain intestinal mucosal barrier function in IBD mice. Here, NR3C2 is linked to inflammatory bowel disease.